Evidence map›Paper›PMID 20354936›Full record

ReviewSeminars in respiratory and critical care medicine2010

Viral infections in lung transplant recipients.

Pali Dedhiya Shah, John F McDyer

Abstract readReview
In one paragraph

Review in Seminars in respiratory and critical care medicine, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 50 citations in OpenAlex.

  1. The search for peripheral tolerance in lung transplantation.Current opinion in pulmonary medicine · 2025
    Review
  2. Review
  3. Risk of Bronchial Complications After Lung Transplantation With RespiratoryTransplant international : official journal of the European Society for Organ Transplantation · 2023
    Article
  4. CD16American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2023
    Article
  5. Donor derived cell free DNA% is elevated with pathogens that are risk factors for acute and chronic lung allograft injury.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2021
    Article
  6. Article
  7. Acute rejection.Journal of thoracic disease · 2017
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Prevention of airway allograft tolerance by polyinosinic:polycytidylic acid requires type I interferon responsiveness for mouse airway obliteration.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2013
    Article
  14. Lung transplant infection.Respirology (Carlton, Vic.) · 2013
    Review
  15. Update on lung transplantation: programmes, patients and prospects.European respiratory review : an official journal of the European Respiratory Society · 2012
    Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Pali Dedhiya ShahDivision of Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
John F McDyer
Johns Hopkins Medicine · USVanderbilt University Medical Center · US

Funding

Development of CMV-specific T Cell Memory in Lung Transplant RecipientsR01AI079175 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MCDYER, JOHN F · 2009 to 2012
$1.6M
NIAID NIH HHS R01 AI079175
6 · The paper itself

Abstract

Viral infections, including beta-herpes viruses and community respiratory viruses, are frequent pathogens in lung transplant recipients. These pathogens have become increasingly recognized as having a significant role in long-term outcomes of lung transplantation, which has been limited by the frequent development of infections, and chronic allograft dysfunction. Community respiratory viruses, such as influenza and respiratory syncytial virus have been associated with both acute rejection and chronic allograft dysfunction, particularly if early treatment was not administered. beta-herpes viruses, particularly cytomegalovirus (CMV), have long been associated with increased mortality in lung transplant recipients, although the advent of effective antiviral strategies has led to improved morbidity and mortality. Because these pathogens have been associated with altered immune responses against the allograft, a better understanding of immunopathogenesis of viral infections may lead to a broader approach to limit the morbidity from these pathogens.

Indexed as

Antiviral AgentsGraft RejectionHumansLung TransplantationOpportunistic InfectionsPrognosisSurvival AnalysisVirus DiseasesAntiviral Agents

Identifiers

PMID20354936
PMCPMC3827906
OpenAlexW2083291013

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.